Latest Nanexa News & Updates

See the latest news and media coverage for Nanexa. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Nanexa

Pharmaceutical company developing long-acting injectable drug products

nanexa.com
Headquarters
Uppsala, Sweden
Founded year
2007
Company type
Public company
Number of employees
25–50
Industry
Medical Equipment, Supplies & Distribution

Last updated

Latest news about Nanexa

In short: Nanexa reported 2026 financial results, secured a $500 million deal with Moderna, and advanced its NEX-22 drug delivery platform.

Company announcements

Nanexa

Nanexa resolves on set-off of SEK 20 million loan

The Board issues shares and warrants to lenders, converting debt to equity, strengthening the balance sheet and preserving liquidity. Dilution is approximately 3.27% from shares and up to 6.34% total.

Unlock all announcements with a

Media coverage

London Stock Exchange

Nanexa publishes annual report for 2025

Nanexa AB (publ) today announces that the Annual Report for 2025 has been published and is available on the company's website Nanexa AB - Financial...

Dagens industri

Nanexa turns operating result from minus to plus

Drug-delivery company Nanexa reports an operating result of 16.7 million kronor (minus 12.0) in the fourth quarter of 2025.

Unlock all articles with a

Never miss news about Nanexa

Track Nanexa and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.